Immuneering Corporation (IMRX) vs SAB Biotherapeutics, Inc. (SABS)
- Immuneering Corporation IMRX 3.59 −1.37%
- SAB Biotherapeutics, Inc. SABS 2.53 −2.32%
Immuneering Corporation and SAB Biotherapeutics, Inc. are both Biotechnology companies. Immuneering Corporation and SAB Biotherapeutics, Inc. are of similar size ($235.7M and $235.5M). SAB Biotherapeutics, Inc. grew revenue faster over the last twelve months: −60.3% against −84.8%. Across the 15 metrics below, SAB Biotherapeutics, Inc. leads on 11 and Immuneering Corporation on 4.
Valuation
Profitability
| Metric | IMRX | SABS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (52.15%) | (19.21%) | (56.36%) |
| Return on assets | (47.31%) | (16.24%) | (48.04%) |
| Return on invested capital | (97.14%) | (38.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack